MENU
+Compare
DVAX
Stock ticker: NASDAQ
AS OF
Nov 13 closing price
Price
$11.16
Change
-$0.10 (-0.89%)
Capitalization
1.31B

DVAX Dynavax Technologies Corp Forecast, Technical & Fundamental Analysis

Dynavax Technologies Corp is a biopharmaceutical company... Show more

Industry: #Biotechnology
DVAX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for DVAX with price predictions
Nov 12, 2025

Aroon Indicator for DVAX shows an upward move is likely

DVAX's Aroon Indicator triggered a bullish signal on November 04, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 190 similar instances where the Aroon Indicator showed a similar pattern. In of the 190 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 05, 2025. You may want to consider a long position or call options on DVAX as a result. In of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for DVAX just turned positive on November 06, 2025. Looking at past instances where DVAX's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

DVAX moved above its 50-day moving average on October 21, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for DVAX crossed bullishly above the 50-day moving average on October 27, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DVAX advanced for three days, in of 290 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DVAX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

DVAX broke above its upper Bollinger Band on November 10, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. DVAX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.457) is normal, around the industry mean (18.827). P/E Ratio (54.600) is within average values for comparable stocks, (71.764). DVAX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.856). DVAX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.031). P/S Ratio (4.174) is also within normal values, averaging (39.291).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
DVAX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

DVAX is expected to report earnings to fall 76.19% to 5 cents per share on February 19

Dynavax Technologies Corp DVAX Stock Earnings Reports
Q4'25
Est.
$0.05
Q3'25
Beat
by $0.08
Q2'25
Beat
by $0.04
Q1'25
Missed
by $0.81
Q4'24
Beat
by $0.01
The last earnings report on November 05 showed earnings per share of 20 cents, beating the estimate of 12 cents. With 1.90M shares outstanding, the current market capitalization sits at 1.31B.
A.I. Advisor
published General Information

General Information

a developer of novel products to prevent and treat infectious diseases

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2100 Powell Street
Phone
+1 510 848-5100
Employees
408
Web
https://www.dynavax.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NMUAX11.650.03
+0.26%
Neuberger Berman Multi-Cap Opp A
QNTAX41.280.03
+0.07%
Meeder Sector Rotation Adviser
SAPYX39.560.02
+0.05%
ClearBridge Appreciation I
FMCAX45.83N/A
N/A
Fidelity Advisor Stock Selec Mid Cp M
CSEYX22.37-0.04
-0.18%
Columbia Select Global Equity Inst3

DVAX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, DVAX has been loosely correlated with ACET. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if DVAX jumps, then ACET could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DVAX
1D Price
Change %
DVAX100%
-0.09%
ACET - DVAX
39%
Loosely correlated
+6.24%
SNDL - DVAX
35%
Loosely correlated
-3.24%
ALKS - DVAX
33%
Poorly correlated
-7.11%
BCRX - DVAX
31%
Poorly correlated
-0.69%
AMRX - DVAX
29%
Poorly correlated
-0.42%
More

Groups containing DVAX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DVAX
1D Price
Change %
DVAX100%
-0.09%
Pharmaceuticals: Generic
industry (214 stocks)
36%
Loosely correlated
-1.00%